T-DM1 ± Pertuzumab als First-line-Option in der Phase-III-Prüfung: MARIANNE-Studie beim HER2-positiven Mammakarzinom | Zendy

Bertrand Coiffier | Zendy; Cornelius F. Waller | Zendy; Semiglazov Vf | Zendy; Sergei Tjulandin | Zendy; Dmitry Bentsion | Zendy; Stephen Chan | Zendy; Rodeina Challand | Zendy; Kun Wang | Zendy; Zhen Chen | Zendy; Laura Kahmann | Zendy; Ulrich Beyer | Zendy; Grit Mehlhorn | Zendy; Falk C. Thiel | Zendy; Vratislav Strnad | Zendy; Peter A. Fasching | Zendy; Michael P. Lux | Zendy; Beibei Zhang | Zendy; Junxue Wang | Zendy; Wensheng Xu | Zendy; Lei Wang | Zendy; Ni Wu | Zendy; Michael Stamatakos | Zendy; Charikleia Stefanaki | Zendy; Konstantinos Kontzoglou | Zendy; Stavroula Masouridi | Zendy; George H. Sakorafas | Zendy; Michael Safioleas | Zendy; Martin Fehr | Zendy; Roger von Moos | Zendy; Markus Furrer | Zendy; Richard Cathomas | Zendy; Karel Krejčí | Zendy; Tomáš Tichý | Zendy; Pavel Hořák | Zendy; Hana Ciferská | Zendy; Marián Hajdúch | Zendy; Josef Srovnal | Zendy; Radek Trojanec | Zendy; Michaela Zezulová | Zendy; Miloslava Zlevorová | Zendy; Lucie Kalinová | Zendy; J Zadražil | Zendy; RalfDieter Hofheinz | Zendy; SalahEddin AlBatran | Zendy; Karsten Ridwelski | Zendy; Christian Görg | Zendy; Klaus Wehle | Zendy; M. Birth | Zendy; Sebastian Fetscher | Zendy; Harald Scheiber | Zendy; Nadine Lukan | Zendy; Florian Lordick | Zendy; Wenkang Liu | Zendy; Xiang-Yang Jiang | Zendy; Jian-Kang Ren | Zendy; Zhenxi Zhang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

T-DM1 ± Pertuzumab als First-line-Option in der Phase-III-Prüfung: MARIANNE-Studie beim HER2-positiven Mammakarzinom

Author(s) -

Bertrand Coiffier,

Cornelius F. Waller,

Semiglazov Vf,

Sergei Tjulandin,

Dmitry Bentsion,

Stephen Chan,

Rodeina Challand,

Kun Wang,

Zhen Chen,

Laura Kahmann,

Ulrich Beyer,

Grit Mehlhorn,

Falk C. Thiel,

Vratislav Strnad,

Peter A. Fasching,

Michael P. Lux,

Beibei Zhang,

Junxue Wang,

Wensheng Xu,

Lei Wang,

Ni Wu,

Michael Stamatakos,

Charikleia Stefanaki,

Konstantinos Kontzoglou,

Stavroula Masouridi,

George H. Sakorafas,

Michael Safioleas,

Martin Fehr,

Roger von Moos,

Markus Furrer,

Richard Cathomas,

Karel Krejčí,

Tomáš Tichý,

Pavel Hořák,

Hana Ciferská,

Marián Hajdúch,

Josef Srovnal,

Radek Trojanec,

Michaela Zezulová,

Miloslava Zlevorová,

Lucie Kalinová,

J Zadražil,

RalfDieter Hofheinz,

SalahEddin AlBatran,

Karsten Ridwelski,

Christian Görg,

Klaus Wehle,

M. Birth,

Sebastian Fetscher,

Harald Scheiber,

Nadine Lukan,

Florian Lordick,

Wenkang Liu,

Xiang-Yang Jiang,

Jian-Kang Ren,

Zhenxi Zhang

Publication year - 2010

Publication title -

onkologie

Language(s) - German

Resource type - Journals

eISSN - 1423-0240

pISSN - 0378-584X

DOI - 10.1159/000321428

Subject(s) - pertuzumab , medicine , breast cancer , trastuzumab , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore